openPR Logo
Press release

Hepatitis D (HDV) - Drug Pipeline Landscape, 2022

08-04-2022 09:50 AM CET | Health & Medicine

Press release from: Global Insight Services

Hepatitis D (HDV) - Drug Pipeline Landscape

Hepatitis D (HDV) - Drug Pipeline Landscape

Hepatitis D, also known as delta hepatitis, is an inflammation of the liver caused by the hepatitis D virus (HDV), which requires HBV for its replication. Hepatitis D infection cannot occur in the absence of hepatitis B virus. HDV-HBV co-infection is considered the most severe form of chronic viral hepatitis due to more rapid progression towards hepatocellular carcinoma and liver-related death.

The primary route of transmission for hepatitis D is contact with infected blood or other bodily fluids. This can happen through sharing needles or drug materials with an infected person or having unprotected sex with an infected person. The signs and symptoms of HDV can include: yellow skin and eyes (jaundice), stomach upset, pain in your belly, throwing up, fatigue, loss of appetite, joint pain, dark urine, light-colored stool.

Read more about Hepatitis D (HDV) - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/hepatitis-d-hdv-drug-pipeline-landscape-2022/

Report Highlights:

Global Insight Service's, Hepatitis D (HDV) - Drug Pipeline Landscape, 2022 report provides an overview of the Hepatitis D pipeline drugs. This report covers detailed insights on Hepatitis D (HDV) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Hepatitis D (HDV) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31055/

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players:

- Antios Therapeutics, Inc
- Eiger BioPharmaceuticals Inc
- Gilead Sciences Inc
- Hepatera Ltd.
- Janssen Research & Development, LLC
- PharmaEssentia
- Replicor Inc.

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31055/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hepatitis D (HDV) - Drug Pipeline Landscape, 2022 here

News-ID: 2697705 • Views:

More Releases from Global Insight Services

U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 to 2033
U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 …
Market Definition An RTD cocktail is a pre-mixed alcoholic beverage that is typically sold in a can or bottle. RTD cocktails are convenient because they require no additional mixing or preparation, making them ideal for parties or other events where alcohol will be served. There are a variety of RTD cocktails available, including popular options such as Moscow Mules, Margaritas, and Bloody Marys. RTD cocktails are typically made with lower-quality alcohol,
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Forecast 2033
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Fore …
Market Definition A space semiconductor is a type of semiconductor device that is designed to function in extreme conditions found in outer space. Space semiconductors must be able to withstand high levels of radiation and extreme temperatures, as well as the vacuum of space. Space semiconductors are used in a variety of space-based applications, including satellites, spacecraft, and telescopes. They are also used in space exploration missions, such as the Mars
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Mühlbauer Group, Primekey Solutions Ab, Thales Group, Safran
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Müh …
Market Definition The E-passport Market represents a transformative shift in travel documentation, offering enhanced security and efficiency compared to traditional passports. Also known as biometric passports, E-passports incorporate a microprocessor chip containing the holder's biometric information, such as fingerprints and facial recognition data, along with personal details. This technology not only mitigates the risk of identity theft and fraud but also expedites border control processes by enabling automated authentication. Market Outlook The E-passport
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research Study, Trends, Development Status, Opportunities, Future Plans, Competitive Landscape And Growth By Forecast 2033
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research …
Market Definition The Oligonucleotide Synthesis Market is a vital component in the biotechnology and pharmaceutical industries, providing customized strands of DNA or RNA sequences for various applications such as genetic research, diagnostics, and therapeutic development. This market encompasses a range of synthesis technologies, including solid-phase synthesis and enzymatic methods, allowing researchers to tailor oligonucleotides with precision. As advancements in genomics, personalized medicine, and synthetic biology drive demand for high-quality oligonucleotides, the

All 5 Releases


More Releases for Hepatitis

Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each